Thursday, October 21, 2021
Home Tags Gilead

Tag: Gilead

Gilead announces steps to expand availability of Remdesivir in India

Gilead Sciences announced that in response to the rapid increase in C-19 cases in India, the company is providing its voluntary licensing...

Remdesivir reduced risk of death in Covid-19 patients: Gilead

Gilead Sciences said additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the...

These are the prices of Remdesivir by Gilead, Hetero & Cipla

Gilead Sciences Inc has priced its Covid-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some...

Price of Remdesivir for COVID-19 under Rs. 5,000: Cipla

BENGALURU: Indian drugmaker Cipla Ltd will price its generic version of Gilead Sciences Inc's antiviral drug remdesivir for use in COVID-19 patients at less than 5,000 rupees ($66),...

Dr Reddy’s inks licensing pact with Gilead for Remdesivir

Hyderabad: Indian generic drug maker Dr Reddy’s Laboratories announced entering into a non-exclusive licensing agreement with Gilead Sciences, which grants the Indian firm...

Indian licensees free to price Remdesivir: Gilead

New Delhi | Mumbai: US-based Gilead Sciences has said its licensed manufacturers in India are free to fix the price of Remdesivir, the...

DCGI approves Remdesivir for COVID-19 patients

Central Drugs Standard Control Organisation (CDSCO) has approved the use of anti-viral drug, remdesivir for the treatment COVID-19 patients, both adults and children, hospitalised...

Gilead seeks marketing authorisation from CDSCO for remdesivir

Gilead Sciences has applied to Central Drugs Standard Control Organisation (CDSCO) seeking marketing authorisation for its anti-viral drug remdesivir, which is being...

Remdesivir close to authorisation for COVID-19 treatment

Remdesivir close to authorisation for COVID-19 treatment BRUSSELS: The head of the European Union's medicines agency Guido Rasi said on...

Jubilant and Gilead sign licensing deal for Remdesivir

Jubilant and Gilead sign licensing deal for Remdesivir MUMBAI: India’s Jubilant Life Sciences and US-based Gilead Sciences signed a non-exclusive licensing agreement for...

Remdesivir will be available globally: Gilead

Remdesivir will be available globally: Gilead Mumbai | New Delhi: Gilead Science Inc has said it is working to build a...

Latest posts

Govt reconstitutes Drugs Technical Advisory Board (DTAB)

Download the list of DTAB members: The ministry of health and family welfare has reconstituted the Drugs Technical Advisory Board (DTAB), adding...

Authors

50 POSTS0 COMMENTS
30 POSTS0 COMMENTS
16 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS